These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 9387979

  • 1. Effects of beta-agonists on dose-response curves.
    Salome C, Woolcock A.
    Eur Respir J; 1997 Oct; 10(10):2434-5. PubMed ID: 9387979
    [No Abstract] [Full Text] [Related]

  • 2. A methacholine challenge dose-response study for development of a pharmacodynamic bioequivalence methodology for albuterol metered- dose inhalers.
    Creticos PS, Adams WP, Petty BG, Lewis LD, Singh GJ, Khattignavong AP, Molzon JA, Martinez MN, Lietman PS, Williams RL.
    J Allergy Clin Immunol; 2002 Nov; 110(5):713-20. PubMed ID: 12417879
    [Abstract] [Full Text] [Related]

  • 3. Therapeutic equivalence of Spiros dry powder inhaler and Ventolin metered dose inhaler. A bioassay using methacholine.
    Ahrens RC, Hendeles L, Clarke WR, Dockhorn RJ, Hill MR, Vaughan LM, Lux C, Han SH.
    Am J Respir Crit Care Med; 1999 Oct; 160(4):1238-43. PubMed ID: 10508813
    [Abstract] [Full Text] [Related]

  • 4. Effect of long-term salmeterol therapy compared with as-needed albuterol use on airway hyperresponsiveness.
    Rosenthal RR, Busse WW, Kemp JP, Baker JW, Kalberg C, Emmett A, Rickard KA.
    Chest; 1999 Sep; 116(3):595-602. PubMed ID: 10492259
    [Abstract] [Full Text] [Related]

  • 5. Dose-response protective effect of salbutamol on methacholine airway responsiveness using pressurized metered dose inhalers and Turbuhalers.
    Wong AG, O'Byrne PM, Lindbladh C, Inman MD, Stâhl E, Hargreave FE.
    Can Respir J; 1998 Sep; 5(2):119-23. PubMed ID: 9707454
    [Abstract] [Full Text] [Related]

  • 6. Reduced dose salbutamol in comparison with standard dosage for symptom relief in asthma.
    Yates DH, Peters MJ, Keatings V, Thomas PS, Barnes PJ.
    Eur Respir J; 1995 Nov; 8(11):1847-51. PubMed ID: 8620950
    [Abstract] [Full Text] [Related]

  • 7. Tolerance to bronchodilation during treatment with long-acting beta-agonists, a randomised controlled trial.
    Haney S, Hancox RJ.
    Respir Res; 2005 Sep 16; 6(1):107. PubMed ID: 16168062
    [Abstract] [Full Text] [Related]

  • 8. Interpretation of positive results of a methacholine inhalation challenge and 1 week of inhaled bronchodilator use in diagnosing and treating cough-variant asthma.
    Irwin RS, French CT, Smyrnios NA, Curley FJ.
    Arch Intern Med; 1997 Sep 22; 157(17):1981-7. PubMed ID: 9308510
    [Abstract] [Full Text] [Related]

  • 9. Recovery time following bronchial challenge.
    Currie GP, Paterson E, Anderson WJ, Lee DK.
    Respir Med; 2005 May 22; 99(5):653. PubMed ID: 15823466
    [No Abstract] [Full Text] [Related]

  • 10. Salbutamol-induced increased airway responsiveness to allergen and reduced protection versus methacholine: dose response.
    Bhagat R, Swystun VA, Cockcroft DW.
    J Allergy Clin Immunol; 1996 Jan 22; 97(1 Pt 1):47-52. PubMed ID: 8568137
    [Abstract] [Full Text] [Related]

  • 11. Functional antagonism with formoterol and salmeterol in asthmatic patients expressing the homozygous glycine-16 beta(2)-adrenoceptor polymorphism.
    Lipworth BJ, Dempsey OJ, Aziz I.
    Chest; 2000 Aug 22; 118(2):321-8. PubMed ID: 10936119
    [Abstract] [Full Text] [Related]

  • 12. Treatment with (R)-albuterol has no advantage over racemic albuterol.
    Barnes PJ.
    Am J Respir Crit Care Med; 2006 Nov 01; 174(9):969-72; discussion 972-4. PubMed ID: 17060668
    [No Abstract] [Full Text] [Related]

  • 13. Magnitude of bronchoprotection of albuterol vs methacholine: relationship to baseline airway caliber.
    Cockcroft DW, Davis BE.
    Chest; 2006 Aug 01; 130(2):622-3. PubMed ID: 16899871
    [No Abstract] [Full Text] [Related]

  • 14. Protection against methacholine bronchoconstriction to assess relative potency of inhaled beta2-agonist.
    Parameswaran KN, Inman MD, Ekholm BP, Morris MM, Summers E, O'Byrne PM, Hargreave FE.
    Am J Respir Crit Care Med; 1999 Jul 01; 160(1):354-7. PubMed ID: 10390425
    [Abstract] [Full Text] [Related]

  • 15. Dose equivalence and bronchoprotective effects of salmeterol and salbutamol in asthma.
    Higham MA, Sharara AM, Wilson P, Jenkins RJ, Glendenning GA, Ind PW.
    Thorax; 1997 Nov 01; 52(11):975-80. PubMed ID: 9487346
    [Abstract] [Full Text] [Related]

  • 16. Inhaled corticosteroids do not prevent the development of tolerance to the bronchoprotective effect of salmeterol.
    Kalra S, Swystun VA, Bhagat R, Cockcroft DW.
    Chest; 1996 Apr 01; 109(4):953-6. PubMed ID: 8635376
    [Abstract] [Full Text] [Related]

  • 17. Diversity of methacholine dose-response curves among asymptomatic non-asthmatics.
    Blais CM, Davis BE, Cockcroft DW.
    Respir Med; 2017 Nov 01; 132():109-111. PubMed ID: 29229081
    [No Abstract] [Full Text] [Related]

  • 18. Long-acting inhaled beta(2)-agonist therapy in asthma.
    Kips JC, Pauwels RA.
    Am J Respir Crit Care Med; 2001 Sep 15; 164(6):923-32. PubMed ID: 11587972
    [No Abstract] [Full Text] [Related]

  • 19. Decreased bronchodilating effect of salbutamol in relieving methacholine induced moderate to severe bronchoconstriction during high dose treatment with long acting beta2 agonists.
    van der Woude HJ, Winter TH, Aalbers R.
    Thorax; 2001 Jul 15; 56(7):529-35. PubMed ID: 11413351
    [Abstract] [Full Text] [Related]

  • 20. Effects of long-acting and short-acting beta-agonists on methacholine dose-response curves in asthmatics.
    Wong AG, O'Shaughnessy AD, Walker CM, Sears MR.
    Eur Respir J; 1997 Feb 15; 10(2):330-6. PubMed ID: 9042628
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.